Longitudinal Quality of Life After Total Neoadjuvant Therapy for Rectal Cancer in the SHORT-FOX Trial

This cohort study examines quality-of-life and functional outcomes among participants in a clinical trial of total neoadjuvant therapy for advanced rectal cancer.

Corresponding Author: Arden M. Morris, MD, MPH, S-SPIRE Center, Department of Surgery, Stanford University School of Medicine, MC5552, 3145 Porter Dr, Wing C0, Palo Alto, CA 94304 (ammsurg@stanford.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.